[go: up one dir, main page]

AR104672A1 - Inhibidores de grelina o-aciltransferasa - Google Patents

Inhibidores de grelina o-aciltransferasa

Info

Publication number
AR104672A1
AR104672A1 ARP160100865A ARP160100865A AR104672A1 AR 104672 A1 AR104672 A1 AR 104672A1 AR P160100865 A ARP160100865 A AR P160100865A AR P160100865 A ARP160100865 A AR P160100865A AR 104672 A1 AR104672 A1 AR 104672A1
Authority
AR
Argentina
Prior art keywords
optionally substituted
grelina
aciltransferasa
inhibitors
oxazolyl
Prior art date
Application number
ARP160100865A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of AR104672A1 publication Critical patent/AR104672A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Epidemiology (AREA)

Abstract

Reivindicación 1: Un compuesto de la fórmula (1), en donde R se selecciona de -alquilo C₁₋₃ opcionalmente sustituido con -OH; -O-alquilo C₁₋₄; pirazolilo, oxazolilo, tiazolilo o tiadiazolilo, en donde pirazolilo, oxazolilo o tiazolilo pueden estar cada uno opcionalmente sustituidos una a dos veces con -CH₃; piridinilo, piridazinilo o pirazinilo, en donde cada uno puede estar opcionalmente sustituido con -Cl; y fenilo opcionalmente sustituido con -OCH₃; o una de sus sales farmacéuticamente aceptables.
ARP160100865A 2015-04-15 2016-03-31 Inhibidores de grelina o-aciltransferasa AR104672A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15382180 2015-04-15

Publications (1)

Publication Number Publication Date
AR104672A1 true AR104672A1 (es) 2017-08-09

Family

ID=52991669

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160100865A AR104672A1 (es) 2015-04-15 2016-03-31 Inhibidores de grelina o-aciltransferasa

Country Status (16)

Country Link
US (1) US10093651B2 (es)
EP (1) EP3283473B1 (es)
JP (1) JP6458168B2 (es)
KR (1) KR20170123693A (es)
CN (1) CN107428723B (es)
AR (1) AR104672A1 (es)
AU (1) AU2016247901A1 (es)
BR (1) BR112017017835A2 (es)
CA (1) CA2976636A1 (es)
EA (1) EA201791992A1 (es)
ES (1) ES2715763T3 (es)
IL (1) IL253969A0 (es)
MX (1) MX2017013073A (es)
TW (1) TWI589574B (es)
WO (1) WO2016168222A1 (es)
ZA (1) ZA201705675B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA45843B1 (fr) 2016-08-05 2021-06-30 Boehringer Ingelheim Int Dérivés d'oxadiazolopyridine utilisés comme inhibiteurs de la ghréline o-acyl transférase (chèvre)
EP3746449B1 (en) 2018-02-02 2022-03-30 Boehringer Ingelheim International GmbH Pyrazole- and indazole-substituted oxadiazolopyridine derivatives for use as ghrelin o-acyl transferase (goat) inhibitors
JP7083397B2 (ja) 2018-02-02 2022-06-10 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング グレリンo-アシルトランスフェラーゼ(goat)阻害剤として使用するためのトリアゾロピリミジン誘導体
CN111655700B (zh) * 2018-02-02 2023-07-18 勃林格殷格翰国际有限公司 作为饥饿素o-酰基转移酶(goat)抑制剂的噁二唑并吡啶衍生物
JP7150032B2 (ja) 2018-02-02 2022-10-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング グレリンo-アシルトランスフェラーゼ(goat)阻害薬として使用するためのヘテロシクリル置換オキサジアゾロピリジン誘導体
CN108610337A (zh) * 2018-05-30 2018-10-02 王丽萍 一种苯并[b]噻吩类化合物及其在肥胖和糖尿病中的应用
BR112022017039A2 (pt) 2020-02-28 2022-11-16 Kallyope Inc Agonistas de gpr40
CN115916789B (zh) 2020-05-22 2025-06-27 勃林格殷格翰国际有限公司 制备烷基7-氨基-5-甲基-[1,2,5]噁二唑并[3,4-b]吡啶羧酸酯的连续方法
ES2984466T3 (es) 2020-05-22 2024-10-29 Boehringer Ingelheim Int Procedimiento de fabricación de 7-amino-5-metil-[1,2,5]oxadiazolo[3,4-b]piridín-carboxilato de alquilo

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005026211A2 (en) 2003-09-05 2005-03-24 Eli Lilly And Company Anti-ghrelin antibodies
US20050070712A1 (en) * 2003-09-26 2005-03-31 Christi Kosogof Pyrimidine derivatives as ghrelin receptor modulators
JP2008515771A (ja) 2004-07-14 2008-05-15 イーライ リリー アンド カンパニー 抗グレリン抗体
CA2587627A1 (en) 2004-11-15 2006-05-26 Eli Lilly And Company Desacyl ghrelin antibodies and therapeutic uses thereof
US7479271B2 (en) 2005-02-23 2009-01-20 Eli Lilly And Company Humanized anti-ghrelin antibodies
JP6106179B2 (ja) 2012-02-24 2017-03-29 武田薬品工業株式会社 芳香環化合物
UA118034C2 (uk) * 2013-11-14 2018-11-12 Елі Ліллі Енд Компані Заміщений піперидилетилпіримідин як інгібітор грелін-o-ацилтрансферази

Also Published As

Publication number Publication date
ZA201705675B (en) 2019-07-31
AU2016247901A1 (en) 2017-09-14
IL253969A0 (en) 2017-10-31
ES2715763T3 (es) 2019-06-06
BR112017017835A2 (pt) 2018-04-10
EP3283473A1 (en) 2018-02-21
JP6458168B2 (ja) 2019-01-23
KR20170123693A (ko) 2017-11-08
US20180086732A1 (en) 2018-03-29
CA2976636A1 (en) 2016-10-20
US10093651B2 (en) 2018-10-09
JP2018511630A (ja) 2018-04-26
WO2016168222A1 (en) 2016-10-20
EA201791992A1 (ru) 2018-03-30
MX2017013073A (es) 2017-12-04
CN107428723A (zh) 2017-12-01
TW201704225A (zh) 2017-02-01
CN107428723B (zh) 2020-05-05
EP3283473B1 (en) 2019-01-02
TWI589574B (zh) 2017-07-01

Similar Documents

Publication Publication Date Title
AR104672A1 (es) Inhibidores de grelina o-aciltransferasa
AR089818A1 (es) Inhibidor de la quinasa que regula la señal de la apoptosis
AR104673A1 (es) Inhibidores de grelina o-aciltransferasa
AR107519A1 (es) Compuestos de piperidina sustituido y su uso
UY36314A (es) NUEVOS COMPUESTOS ANTAGONISTAS DE INTEGRINA avß6.
CR20150418A (es) Compuestos de tetrahidropirrolotiazina
CO2019005165A2 (es) Compuesto de piridona como inhibidor de c-met
CR20160548A (es) Nuevos Derivados de Pirazolo Pirimidina y su Uso como Inhibidores de MALT1
UA118259C2 (uk) Гетероциклічні аміди як інгібітори кінази
BR112017006253A2 (pt) novos compostos
AR097866A1 (es) Derivados de 4-azaindol
AR099376A1 (es) Compuestos de diaminopirimidilo sustituidos, sus composiciones y métodos de tratamiento con aquellos
AR095339A1 (es) Compuestos moduladores alostericos de la hemoglobina
AR111469A1 (es) Sal de un compuesto del derivado de aminopiridina, una forma cristalina de la misma, y un proceso para preparar la misma
ECSP17054980A (es) Inhibidores selectivos de bace1
PE20151509A1 (es) Derivado de piridina monociclico
EA202091120A3 (ru) Производные 2,4-тиазолинидона в лечении расстройств центральной нервной системы
AR105967A1 (es) Sales de un inhibidor de pim quinasa
CO2019004978A2 (es) Compuestos terapéuticos y métodos para utilizarlos
MX2016017405A (es) Compuestos derivados de 2-(3-piridinil)-1h-benzimidazol y medicamentos que los contienen.
MY193239A (en) Novel b-lactamase inhibitors
AR104899A1 (es) Compuestos reguladores del crecimiento vegetal
AR101523A1 (es) Compuestos para el tratamiento de condiciones asociadas con la actividad de dgat1
AR092145A1 (es) Tris-(hetero)aril-pirazoles y su uso
MX390752B (es) Compuesto heterociclico.

Legal Events

Date Code Title Description
FB Suspension of granting procedure